Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Clinical trial NCT06384222 · RECRUITING
Trial details
- NCT number
- NCT06384222
- Sponsor
- Ivan de Kouchkovsky, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2027-09-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.